Jonathan David Schwartz

Jonathan David Schwartz is a declared insider at 2 companies (chief executive); the most frequent names are Rocket Pharmaceuticals, Inc. and Tabula Rasa HealthCare, Inc. We count 28 filings; the first trade dates from 1 February 2021 and the latest from 18 November 2025.

On the market, this insider has only sold: 19 sales, €3.0M in total. The rest of the record consists of 4 share grants and 3 option exercises. In 2025 alone, the filings show no purchases and 10 sales.

The latest filing, published on 20 November 2025, reports an open-market sale of €6,550 in Rocket Pharmaceuticals, Inc. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.